Context Therapeutics to Participate in Upcoming Investor Conferences
Provided By GlobeNewswire
Last update: Feb 19, 2025
PHILADELPHIA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or “Company”) (Nasdaq: CNTX), a biopharmaceutical company advancing T cell engagers for solid tumors, today announced that the Company will participate in the following investor conferences:
Read more at globenewswire.com
